ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GSK Gsk Plc

1,305.00
5.00 (0.38%)
Last Updated: 15:30:40
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  5.00 0.38% 1,305.00 1,305.00 1,306.00 1,315.00 1,300.00 1,300.00 3,488,246 15:30:40
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1889 10.98 53.89B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,300p. Over the last year, Gsk shares have traded in a share price range of 1,282.50p to 1,820.00p.

Gsk currently has 4,145,087,815 shares in issue. The market capitalisation of Gsk is £53.89 billion. Gsk has a price to earnings ratio (PE ratio) of 10.98.

Gsk Share Discussion Threads

Showing 33676 to 33699 of 34050 messages
Chat Pages: Latest  1350  1349  1348  1347  1346  1345  1344  1343  1342  1341  1340  1339  Older
DateSubjectAuthorDiscuss
10/10/2024
09:28
Great settlement for GSK

$2.2bn

A bargain


"Worries had mounted over how many billions GSK might have to pay, with analyst estimates reaching $8 billion last year and even $45 billion in 2022.

That has weighed heavily on its share price, with tens of billions of dollars wiped off the market value of companies linked to the drug. Shares recovered as the cases were eventually settled. Bloomberg

geckotheglorious
10/10/2024
09:23
Yes now good value, investors hate uncertainty, now settled, good news.
montyhedge
10/10/2024
08:52
Even with today's settlement news and 6% jump in share price (so far), GSK continues to be seriously undervalued and remains an outstanding BUY.
tradermichael
10/10/2024
08:39
GSK's investment case has significantly improved following its settlement of liability cases related to its discontinued Zantac drug, Deutsche Bank analysts Emmanuel Papadakis and Niall Alexander say in a note. The resolve is a surprising and positive twist to the investment case as it came sooner than expected and should ease investors concerns that had weighed on the shares, they say. Even with the share boost following the news, the pharma giant still seems undervalued based on its projected earnings for 2025, they add.
dplewis1
10/10/2024
08:16
Anyone re-investing their GSK dividend (paid today)?
tradermichael
10/10/2024
08:00
In corporate news, GSK surged after agreeing to pay $2.2bn to settle about 80,000 Zantac lawsuits in the US.

In a statement released after the close of markets on Wednesday, the pharmaceuticals firm said it had reached an agreement with 10 firms who represent 93% of the Zantac (ranitidine) state court product liability cases pending against it in the US.

GSK also said it had agreed to pay $70m to resolve a whistleblower complaint by a laboratory called Valisure, which alleged that the pharmaceuticals company had defrauded the US government by concealing the cancer risks of heartburn drug Zantac for decades.

tradermichael
10/10/2024
07:54
+6% and a dividend paid out today...
mister md
10/10/2024
07:10
Indeed, looks like a positive view from market
simon8
10/10/2024
07:08
Opening USD4bn or so up seems to indicates market relief.
patientcapital
10/10/2024
06:44
What happened to the Delaware supreme court appeal, have I missed something? Not sure how price will react but only 15 mins to find out...
simon8
10/10/2024
05:29
GSK to Pay Over $2 Billion in Bid to End Most U.S. Zantac Lawsuits

GSK agreed to pay more than $2 billion to settle almost all remaining liability cases in the U.S. over allegations its discontinued heartburn medicine Zantac causes cancer.

The British pharmaceutical giant said Wednesday that it had struck agreements with 10 plaintiff firms aimed at resolving 93%, or about 80,000, of pending Zantac lawsuits in the country for up to $2.2 billion.

Write to singaporeeditors@dowjones.com

waldron
09/10/2024
22:14
USD2.2bn seems a relative bargain compared with the 5 or so being speculated about a few months ago. On balance good news.
patientcapital
09/10/2024
20:28
It's the USA. Pay to settle or we drag you out for years for our own pockets, not the plaintiff.
dope007
09/10/2024
20:25
Settlement of Zantac cases for up to $2.2 billion. I think this is wrong and the company has managed this really badly. I have sympathy with anyone with cancer but the 16 studies showed clearly that Zantac was not the cause. Despicable lawyers.
rikky72
09/10/2024
20:01
All eyes are on the budget now. FTSE in a holding pattern.
pander45
09/10/2024
19:45
Get a result in the appeal and £19-20 a lot more likely than £13!
rikky72
09/10/2024
19:44
ADRs are up 6%, hardly soaring. Which is handy because it might be more of a slow burn up.
hpcg
09/10/2024
19:42
Up 6% stateside, so expecting that and some tomorrow here
dope007
09/10/2024
18:35
Pander isn't getting his 13 quid that's for sure
dplewis1
09/10/2024
18:21
Shame day b4 divi paid out. Will be getting less shares tomorrow than if received today
watfordhornet
09/10/2024
18:04
Dynamite....
c £1.7Billion (TG for strong pound). Cheap, cheap, cheap.
And knock off £500 million off for potential legal fee savings over the next few years, and tax write offs on the payment.
GSK should be £20 given peer valuations.

cumnor
09/10/2024
18:04
Pay $2.2 billion to resolve approx 80,000 cases, works out around $27,500 per case, seems cheap to me, onwards and upwards....hopefully!
wm2020
09/10/2024
18:03
Looks like a big rise tomorrow up nearly 8 percen in USA
timothyo2
09/10/2024
18:01
Kill or fill at £16.00?
tahmina1
Chat Pages: Latest  1350  1349  1348  1347  1346  1345  1344  1343  1342  1341  1340  1339  Older

Your Recent History

Delayed Upgrade Clock